At the time of writing, Jaguar Health Inc [JAGX] stock is trading at $0.08, down -2.38%. An important factor to consider is whether the stock is rising or falling in short-term value. The JAGX shares have gain 6.49% over the last week, with a monthly amount glided 0.37%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 8, April 2024, Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq’s Bid Price Requirement. In a post published today on Yahoo Finance, Top line results forthcoming for company’s phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea.
From an analyst’s perspective:
Jaguar Health Inc [NASDAQ: JAGX] stock has seen the most recent analyst activity on July 07, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $5. Previously, Rodman & Renshaw started tracking the stock with Buy rating on July 11, 2017, and set its price target to $2.
For the past year, the stock price of Jaguar Health Inc fluctuated between $0.05 and $1.22. Jaguar Health Inc [NASDAQ: JAGX] shares were valued at $0.08 at the most recent close of the market.
Analyzing the JAGX fundamentals
According to Jaguar Health Inc [NASDAQ:JAGX], the company’s sales were 9.76M for trailing twelve months, which represents an -29.45% plunge. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -3.48%, Pretax Profit Margin comes in at -4.29%, and Net Profit Margin reading is -4.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.81, Equity is -8.56 and Total Capital is -0.92. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 7.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.0769 points at the first support level, and at 0.0717 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.0891, and for the 2nd resistance point, it is at 0.0961.
Jaguar Health Inc [JAGX] reported earnings per share of -$0.55 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.23/share, meaning a difference of $0.68 and a surprise factor of 55.30%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.69 per share as compared to estimates of -$1.53 per share, a difference of $0.84 representing a surprise of 54.90%.
Ratios To Look Out For
It is important to note that Jaguar Health Inc [NASDAQ:JAGX] has a current ratio of 2.00. On the other hand, the Quick Ratio is 1.34, and the Cash Ratio is 0.46. Considering the valuation of this stock, the price to sales ratio is 1.75, the price to book ratio is 1.21.
